510(k) Report

510(k) · Cleared

Cleared

B.Braun Premixed Dialysate

K034066510(k) TraditionalCleared Mar 3, 200463-day reviewClass II21 CFR 876.5820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

B.Braun Medical, Inc. · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Cleared on Mar 3, 2004 as substantially equivalent to K022913 (Nxstage Medical, Inc., 2002) and 2 other predicates after a 63-day review. Its family tree reaches back 3 generations to 1987.

Decided
Mar 3, 2004
Review
63 days
Class
Class II
Product code
KPO
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K864265 (1987). 7 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1991: 1 other ancestor2002: 1 other ancestor2001: 1 other ancestor2000: 1 other ancestorK864265 · Hemodialysis Bath Concentrate Solutions for Hemodi · Dial Medical of Florida, Inc. · 1987K013448 · Prismasate · Gambro Renal Products · 2002K022913 · Nxstage Premixed Dialysate · Nxstage Medical, Inc. · 200219851990199520002005
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 3 other ancestors K022913 · Nxstage Premixed Dialysate · Nxstage Medical, Inc. · 2002K013448 · Prismasate · Gambro Renal Products · 2002K864265 · Hemodialysis Bath Concentrate Solutions for Hemodi · Dial Medical of Florida, Inc. · 19870
  1. Root · 3 generations backK864265 Hemodialysis Bath Concentrate Solutions for HemodiDial Medical of Florida, Inc. · 1987
  2. 2 generations backK013448 PrismasateGambro Renal Products · 2002
  3. 1 generation backK022913 Nxstage Premixed DialysateNxstage Medical, Inc. · 2002
  4. This deviceK034066 B.Braun Premixed DialysateB.Braun Medical, Inc. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K864265Hemodialysis Bath Concentrate Solutions for HemodiDial Medical of Florida, Inc.1987—
−2K013448PrismasateGambro Renal Products2002—
−1K022913Nxstage Premixed DialysateNxstage Medical, Inc.2002—
0 (this device)K034066B.Braun Premixed DialysateB.Braun Medical, Inc.2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
200010
200110
200210
FIG. 1 — Lineage of K034066, 1987–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPO device

  1. #1 K233159 pureFLOW 402, pureFLOW 400, pureFLOW 406…score 14.5 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022913Nxstage Premixed Dialysate
Summary page 2
…emtarket Notification B. Braun Premnixed Dialysate SUBSTANTIAL EQUIVALENCE (continued): · NxStage Premixed Dialysate (K022913, cleared 10/21/02) · PrismaSate Dialysis Solutions (KO13448, cleared 01/15/02)…
Nxstage Medical, Inc.2002—
*K013448Prismasate
Summary page 1
…ucts - Gambro PrismaSate Dialysis Solutions for Continuous Renal Replacement Therapy (K013448) Baxter Healthcare Corporation -Baxter Premixed Dialysate for…
Gambro Renal Products2002—
*K910270Premixed Dialysate for Hemodiafiltration
Summary page 1
…(K013448) Baxter Healthcare Corporation -Baxter Premixed Dialysate for Liemodiafiltration (K9 10270) DESCRIPTION: The B. Braun Premixed Dialysate Solutions are a family of…
Baxter Healthcare Corp1991—

Also cleared against K022913: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 1.4 years on median.
  • None of the 7 ancestors has a recall.
  • 1 other device also cites its predicate K022913.

How does its category compare?

All KPO devices

KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPO

2in 2025

2007: 22008: 22009: 12011: 12012: 22013: 12014: 22015: 12016: 12017: 32018: 22020: 52021: 12022: 22023: 32024: 32025: 22026 (partial year): 2
2007high 5 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPO

112in 2024

2017: 192 days median2020: 270 days median2023: 263 days median2024: 112 days median
2007high 270 (2020) · low 112 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPO

6in 2025

2007: 52008: 22009: 12011: 22012: 102015: 32016: 12017: 12018: 112019: 12020: 312022: 22024: 12025: 62026 (partial year): 9
2007high 31 (2020) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KPO

95in 2025

2007: 52008: 82009: 32010: 1072011: 2232012: 702013: 3,8972014: 15,9162015: 8,3402016: 2402017: 802018: 972019: 792020: 2442021: 632022: 252023: 592024: 2592025: 95
2007high 15,916 (2014) · low 3 (2009)2025

MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—55
20082—28
20091—13
20100—0107
20111—2223
20122—1070
20131—03,897
20142—015,916
20151—38,340
20161—1240
20173192180
20182—1197
20190—179
2020527031244
20211—063
20222—225
20233263059
202431121259
20252—695
20262—9—

What is it indicated for?

B. Braun Premixed Dialysate is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K034066: B.Braun Premixed Dialysate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K034066

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026